• Leica Microsystems, Columbia University team to develop and market SCAPE microscopy

    The agreement will commercialize swept confocally aligned planar excitation (SCAPE) microscopy, which forms 3D images of living samples.
    Nov. 10, 2016
    2 min read

    Leica Microsystems CMS (Wetzlar, Germany) has entered into an exclusive, worldwide licensing agreement with Columbia University (New York, NY) to commercialize swept confocally aligned planar excitation (SCAPE) microscopy, a method developed at Columbia that forms 3D images of living samples by scanning them with a sheet of laser light.

    Related: Neuroscience trailblazer wins BRAIN Initiative grant for high-speed microscopy method

    SCAPE's capabilities include imaging individual neurons firing throughout the brain of adult fruit flies and tracking calcium waves through cells in the beating heart of a zebrafish, among others. SCAPE also stands to create new inroads for understanding diseases such as cancer, and for the development of new drugs and therapies.

    SCAPE microscopy was developed in the laboratory of Elizabeth Hillman, Ph.D., associate professor of biomedical engineering and radiology at Columbia University and a principal investigator at Columbia's Mortimer B. Zuckerman Mind Brain Behavior Institute. As the method is able to scan and image a moving light sheet through a single, stationary objective lens, it delivers 3D imaging speeds that are 10–100 times faster than conventional point-scanning microscopes while maintaining the benefits of light-sheet imaging, including low photodamage.

    The technology was recognized in late 2015 with a grant award from the National Institutes of Health BRAIN Initiative.

    Sign up for Laser Focus World Newsletters
    Get the latest news and updates.

    Voice Your Opinion!

    To join the conversation, and become an exclusive member of Laser Focus World, create an account today!